UNSPSC 51201617: Rabies vaccine

This classification denotes a vaccine for an acute viral cns infection affecting mammals, including humans, which is caused by the rabies virus (a type species of lyssavirus) and which usually spreads by contamination with virus-laden saliva of bites of rabid animals, most especially dogs, cats, bats, foxes, raccoons, skunks, and wolves. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis.

UNSPSC 51201617 Rabies vaccine is a Commodity code under which state and local health departments procure immunization products for population health and disease prevention programs. Recent state and local solicitations under this code show activity in vaccine procurement, though the opportunities block contains a sole source notice for yellow fever vaccine rather than rabies vaccine specifically—a mismatch suggesting that state procurement systems may tag vaccine solicitations broadly under related immunization codes. State health departments are the primary issuing bodies soliciting under this code tier, reflecting the concentration of immunization procurement authority at the state level.

The Mississippi State Department of Health posted a sole source procurement notice on July 13, 2026, for yellow fever vaccine from Sanofi Pasteur, Inc., with an objection deadline of August 3, 2026 at 10:00 a.m. CST. The notice permits any entity to challenge the sole source classification by demonstrating alternative vendor capacity; if substantiated objections are received, the department will conduct a competitive bid or selection process, or if it determines exclusivity, appeal to the Public Procurement Review Board. The notice does not disclose quantity, contract term, estimated value, or pricing. The geographic scope of recent activity appears limited to Mississippi; broader state activity under this code is not evident from the source.